|
|
Dermatofibrosarcoma
|
|
Dermatofibrosarcoma
Committee for Orphan Medicinal Products July 2005 MeetingJul 22, 2005
...days). Imatinib mesilate, from Novartis Europharm Limited, for treatment of dermatofibrosarcoma protuberans (review time: 32 days). ...
- PharmaLive.com
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Dermatofibrosarcoma
you may want to try searching the Internet using the Google search box below.
|
|
|